ClinicalTrials.Veeva

Menu

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis (SEWORRA)

U

University Hospital, Rouen

Status and phase

Completed
Phase 4

Conditions

Rheumatoid Arthritis

Treatments

Drug: Rituximab
Device: ESAOTE MyLab60

Study type

Interventional

Funder types

Other

Identifiers

NCT01765374
2010/081/HP

Details and patient eligibility

About

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • failure to at least one TNF-blocking agent

Exclusion criteria

  • pregnant or childbearing woman
  • Rituximab contraindication
  • woman unable to use contraceptive means

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

rituximab
Experimental group
Description:
Only one arm; all patients are treated by rituximab (monotherapy or in combination with conventional DMARD)
Treatment:
Drug: Rituximab
Device: ESAOTE MyLab60

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems